BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Art Pappas will be on a panel titled "Update on Capital Availability for Indiana Companies" at Burrill's Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
